1. Ma, Shuoshuo, Ma, Yang, Qi, Feiyu, Lu, Zheng, Zhang, Dengyong. 2023. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis. In World journal of surgical oncology, 21, 293. doi:10.1186/s12957-023-03176-6. https://pubmed.ncbi.nlm.nih.gov/37718459/
2. Zeng, Jing, Ma, Xiao, Wang, Jinjing, Li, Zhiyuan, Fang, Yi. 2019. Down-regulated HSDL2 expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma. In Bioscience reports, 39, . doi:10.1042/BSR20190425. https://pubmed.ncbi.nlm.nih.gov/31101684/
3. Yang, Xiaxin, Zhang, Jianhang, Wang, Zhihao, Zhao, Xiuhe, Xu, Shuo. 2024. Mitochondria-related HSDL2 is a potential biomarker in temporal lobe epilepsy by modulating astrocytic lipid metabolism. In Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 21, e00447. doi:10.1016/j.neurot.2024.e00447. https://pubmed.ncbi.nlm.nih.gov/39245623/
4. Jia, Ling-Hua, Hu, Mei-Di, Liu, Yuan, Wang, Jin-Gen, Li, Qiu-Gen. 2019. HSDL2 Promotes Bladder Cancer Growth In Vitro and In Vivo. In International journal of medical sciences, 16, 654-659. doi:10.7150/ijms.31288. https://pubmed.ncbi.nlm.nih.gov/31217732/
5. Dong, Bing, Yang, Yang, Han, Anna, Wang, Yixuan, Piao, Junjie. 2019. Ectopic expression of HSDL2 is related to cell proliferation and prognosis in breast cancer. In Cancer management and research, 11, 6531-6542. doi:10.2147/CMAR.S205316. https://pubmed.ncbi.nlm.nih.gov/31372054/
6. Cheng, Y, He, X, Wang, L, Hu, J, Hu, J. . [HSDL2 overexpression promotes rectal cancer progression by regulating cancer cell cycle and promoting cell proliferation]. In Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 43, 544-551. doi:10.12122/j.issn.1673-4254.2023.04.06. https://pubmed.ncbi.nlm.nih.gov/37202189/
智鼠故事 
